BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17602936)

  • 1. C-reactive protein and heart failure after myocardial infarction in the community.
    Bursi F; Weston SA; Killian JM; Gabriel SE; Jacobsen SJ; Roger VL
    Am J Med; 2007 Jul; 120(7):616-22. PubMed ID: 17602936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.
    Suleiman M; Khatib R; Agmon Y; Mahamid R; Boulos M; Kapeliovich M; Levy Y; Beyar R; Markiewicz W; Hammerman H; Aronson D
    J Am Coll Cardiol; 2006 Mar; 47(5):962-8. PubMed ID: 16516078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
    Gheno G; Libardoni M; Zeppellini R; Cucchini F
    Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein in acute myocardial infarction: association with heart failure.
    Berton G; Cordiano R; Palmieri R; Pianca S; Pagliara V; Palatini P
    Am Heart J; 2003 Jun; 145(6):1094-101. PubMed ID: 12796768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Hein HO; Hansen JF
    J Intern Med; 2006 Oct; 260(4):377-87. PubMed ID: 16961675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation.
    Bursi F; Enriquez-Sarano M; Nkomo VT; Jacobsen SJ; Weston SA; Meverden RA; Roger VL
    Circulation; 2005 Jan; 111(3):295-301. PubMed ID: 15655133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
    Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction.
    Kalogeropoulos AP; Chiladakis JA; Sihlimiris I; Koutsogiannis N; Alexopoulos D
    J Card Fail; 2008 Apr; 14(3):225-31. PubMed ID: 18381186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for heart failure in patients with one prior myocardial infarction episode.
    Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
    Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative C reactive protein levels and acute myocardial infarction complications in a Hispanic population: an observational analytical pilot study.
    Rentas E; Pérez Arzola M; Bredy R
    Bol Asoc Med P R; 2006; 98(4):284-9. PubMed ID: 19610570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
    Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
    Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction.
    Aronson D; Boulos M; Suleiman A; Bidoosi S; Agmon Y; Kapeliovich M; Beyar R; Markiewicz W; Hammerman H; Suleiman M
    Am J Cardiol; 2007 Sep; 100(5):753-7. PubMed ID: 17719315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.
    Estensen ME; Hognestad A; Syversen U; Squire I; Ng L; Kjekshus J; Dickstein K; Omland T
    Am Heart J; 2006 Nov; 152(5):927.e1-6. PubMed ID: 17070161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction.
    Kohno T; Anzai T; Naito K; Ohno Y; Kaneko H; Li HC; Sugano Y; Maekawa Y; Iwanaga S; Asakura Y; Yoshikawa T; Ogawa S
    Cardiology; 2007; 107(4):386-94. PubMed ID: 17284900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.
    Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
    Clin Biochem; 2007 Mar; 40(5-6):326-9. PubMed ID: 17292342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.